COMMUNIQUÉS West-GlobeNewswire

Inovalon Announces Third Quarter 2018 Earnings Conference Call
24/10/2018
BOWIE, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it will hold a [...]
KemPharm Presents Data from Intranasal and Intravenous Human Abuse Potential Trials of KP415 Prodrug at the American Academy of Child & Adolescent Psychiatry Meeting
24/10/2018
CORALVILLE, Iowa, Oct. 24, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the presentation of [...]
Myriad to Announce Fiscal First-Quarter 2019 Financial Results on November 6, 2018
24/10/2018
SALT LAKE CITY, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal first-quarter 2018 sales [...]
Helius Medical Technologies, Inc. Announces Second Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States
24/10/2018
NEWTOWN, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that its [...]
Breathtec Announces Closing of Private Placement
24/10/2018
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) ( [...]
Evogene Financial Results for the Third Quarter of 2018 Earnings Announcement Schedule
24/10/2018
REHOVOT, Israel, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its [...]
miRagen Therapeutics to Report Third Quarter 2018 Financial Results and Host Conference Call on November 7, 2018
24/10/2018
BOULDER, Colo., Oct. 24, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
Optos and Amydis Establish Clinical Alliance to Develop Early Diagnostic Test for Alzheimer’s Disease
24/10/2018
LOS ANGELES, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Optos Plc, a subsidiary of Nikon Corporation, Japan, and Amydis, Inc. today announced a clinical alliance focused on the development of an eye test by Amydis to detect [...]
BeiGene Announces Acceptance of its New Drug Application in China and Top-Line Pivotal Data for Zanubrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
24/10/2018
BEIJING, China, and CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Sharps Compliance Reports Fiscal 2019 First Quarter Results
24/10/2018
First quarter 2019 revenue increased to $10.3 million with gross margin of 33%, net income of $0.1 million and break-even net income per share Unused Medication solutions business increased 40% Route-based business [...]
Tetra Bio-Pharma Appoints Richard Giguère Chief Executive Officer of Tetra Natural Health
24/10/2018
ORLEANS, Ontario, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the appointment of Richard [...]
Natus Medical Announces Third Quarter Financial Results
24/10/2018
Reports record third quarter revenue of $130.6 million Reports third quarter GAAP loss per share of $0.17 and non-GAAP earnings per share of $0.40 Updates annual revenue and earnings guidance for 2018 PLEASANTON, Calif [...]
TRU NIAGEN® Daily Serving Strengthened Under FDA’s NDI Notification
24/10/2018
ChromaDex increases capsule serving to 150mg TRU NIAGEN ® (nicotinamide riboside), following successful New Dietary Ingredient (NDI) notification from FDA LOS ANGELES, Oct. 24, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]
Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma
24/10/2018
Agreement will see Emblem export to one of the world’s largest legal medical cannabis markets TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company"), today announced [...]
ViroGates releases third quarter 2018 results
24/10/2018
Company announcement no. 7-2018 Birkerød, 24 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for [...]
Mesoblast Expands Partnership With JCR Pharmaceuticals for Treatment of Wound Healing in Epidermolysis Bullosa
24/10/2018
NEW YORK and MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for wound healing [...]
Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm
24/10/2018
Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Company will host two investor events in October. At both [...]
Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland
24/10/2018
Orion Corporation Press Release 24 October 2018 at 12.30 p.m. EEST Orion and Amgen to collaborate on the commercialisation of AMGEVITA ® (biosimilar adalimumab) in Finland Orion Corporation and Amgen have signed an [...]
Opthea To Present Update at the Ophthalmology Innovation Summit in Chicago
24/10/2018
MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases, announced today that Dr [...]

Pages